BPDCN
Wei Wang, MD, PhD, and colleagues conducted the study and published its findings in Cancers.
The combination led to an overall survival rate of nearly 75% in patients with BPDCN...
First-line treatment with tagraxofusp led to an overall response rate of 75% in patients with blastic plasmacytoid...
Advertisement
Study finds BM CH was present in nearly two-thirds of BPDCN patients and particularly prevalent in elderly patients.
Clinicians who specialize in BPDCN discuss the disease and novel therapeutic approaches to treating patients with BPCDN.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.